GENE ONLINE|News &
The Longevity Leap: From Weight Loss to Lifespan Extension as Health Becomes an Asset Class
Advances in cardiometabolic science are shifting longevity from lifespan extension to healthspan optimization, with biological age clocks, metabolic biomarkers, and next-generation therapies enabling measurable reductions in disease burden, mortality risk, and age-related functional decline while reshaping global health policy and investment strategies. Image: Shutterstock
The medical community is currently witnessing a historic pivot as cardiometabolic health transitions from a specialized field into the primary engine of the global longevity economy. By 2026, the strategic focus has shifted from managing chronic illness to maximizing “healthspan”—the number of years a person remains functionally vibrant. High-level institutions like The Lancet Diabetes & … The Longevity Leap: From Weight Loss to Lifespan Extension as Health Becomes an Asset Class Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.
GO Prime with only $1.49 now
LATEST
Definium’s Psychedelic Anxiety Drug DT120 Moves Closer to the Mainstream With a Phase 3 Win
2026-08-14
JAMA Network Open Study Links Agent Orange and Burn Pit Exposure to Veteran Health Outcomes
2026-08-14
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
